Copyright Reports & Markets. All rights reserved.

Global Breast Biopsy Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Breast Biopsy Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Needle-Based Biopsy Systems
      • 1.4.3 Breast Biopsy Needles
      • 1.4.4 Biopsy Imaging Guidance Systems
      • 1.4.5 Others
    • 1.5 Market by Application
      • 1.5.1 Global Breast Biopsy Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 ASCs
      • 1.5.4 Research Centers
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Breast Biopsy Market Size
    • 2.2 Breast Biopsy Growth Trends by Regions
      • 2.2.1 Breast Biopsy Market Size by Regions (2014-2025)
      • 2.2.2 Breast Biopsy Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Breast Biopsy Market Size by Manufacturers
      • 3.1.1 Global Breast Biopsy Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Breast Biopsy Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Breast Biopsy Market Concentration Ratio (CR5 and HHI)
    • 3.2 Breast Biopsy Key Players Head office and Area Served
    • 3.3 Key Players Breast Biopsy Product/Solution/Service
    • 3.4 Date of Enter into Breast Biopsy Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Breast Biopsy Market Size by Type (2014-2019)
    • 4.2 Global Breast Biopsy Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Breast Biopsy Market Size (2014-2019)
    • 5.2 Breast Biopsy Key Players in United States
    • 5.3 United States Breast Biopsy Market Size by Type
    • 5.4 United States Breast Biopsy Market Size by Application

    6 Europe

    • 6.1 Europe Breast Biopsy Market Size (2014-2019)
    • 6.2 Breast Biopsy Key Players in Europe
    • 6.3 Europe Breast Biopsy Market Size by Type
    • 6.4 Europe Breast Biopsy Market Size by Application

    7 China

    • 7.1 China Breast Biopsy Market Size (2014-2019)
    • 7.2 Breast Biopsy Key Players in China
    • 7.3 China Breast Biopsy Market Size by Type
    • 7.4 China Breast Biopsy Market Size by Application

    8 Japan

    • 8.1 Japan Breast Biopsy Market Size (2014-2019)
    • 8.2 Breast Biopsy Key Players in Japan
    • 8.3 Japan Breast Biopsy Market Size by Type
    • 8.4 Japan Breast Biopsy Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Breast Biopsy Market Size (2014-2019)
    • 9.2 Breast Biopsy Key Players in Southeast Asia
    • 9.3 Southeast Asia Breast Biopsy Market Size by Type
    • 9.4 Southeast Asia Breast Biopsy Market Size by Application

    10 India

    • 10.1 India Breast Biopsy Market Size (2014-2019)
    • 10.2 Breast Biopsy Key Players in India
    • 10.3 India Breast Biopsy Market Size by Type
    • 10.4 India Breast Biopsy Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Breast Biopsy Market Size (2014-2019)
    • 11.2 Breast Biopsy Key Players in Central & South America
    • 11.3 Central & South America Breast Biopsy Market Size by Type
    • 11.4 Central & South America Breast Biopsy Market Size by Application

    12 International Players Profiles

    • 12.1 BD
      • 12.1.1 BD Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Breast Biopsy Introduction
      • 12.1.4 BD Revenue in Breast Biopsy Business (2014-2019)
      • 12.1.5 BD Recent Development
    • 12.2 C.R. Bard
      • 12.2.1 C.R. Bard Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Breast Biopsy Introduction
      • 12.2.4 C.R. Bard Revenue in Breast Biopsy Business (2014-2019)
      • 12.2.5 C.R. Bard Recent Development
    • 12.3 Hologic
      • 12.3.1 Hologic Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Breast Biopsy Introduction
      • 12.3.4 Hologic Revenue in Breast Biopsy Business (2014-2019)
      • 12.3.5 Hologic Recent Development
    • 12.4 Leica Biosystems
      • 12.4.1 Leica Biosystems Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Breast Biopsy Introduction
      • 12.4.4 Leica Biosystems Revenue in Breast Biopsy Business (2014-2019)
      • 12.4.5 Leica Biosystems Recent Development
    • 12.5 Argon Medical Devices
      • 12.5.1 Argon Medical Devices Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Breast Biopsy Introduction
      • 12.5.4 Argon Medical Devices Revenue in Breast Biopsy Business (2014-2019)
      • 12.5.5 Argon Medical Devices Recent Development
    • 12.6 Aurora Imaging
      • 12.6.1 Aurora Imaging Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Breast Biopsy Introduction
      • 12.6.4 Aurora Imaging Revenue in Breast Biopsy Business (2014-2019)
      • 12.6.5 Aurora Imaging Recent Development
    • 12.7 Carestream Health
      • 12.7.1 Carestream Health Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Breast Biopsy Introduction
      • 12.7.4 Carestream Health Revenue in Breast Biopsy Business (2014-2019)
      • 12.7.5 Carestream Health Recent Development
    • 12.8 Cook Medical
      • 12.8.1 Cook Medical Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Breast Biopsy Introduction
      • 12.8.4 Cook Medical Revenue in Breast Biopsy Business (2014-2019)
      • 12.8.5 Cook Medical Recent Development
    • 12.9 Fischer Medical Technologies
      • 12.9.1 Fischer Medical Technologies Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Breast Biopsy Introduction
      • 12.9.4 Fischer Medical Technologies Revenue in Breast Biopsy Business (2014-2019)
      • 12.9.5 Fischer Medical Technologies Recent Development
    • 12.10 Intact Medical
      • 12.10.1 Intact Medical Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Breast Biopsy Introduction
      • 12.10.4 Intact Medical Revenue in Breast Biopsy Business (2014-2019)
      • 12.10.5 Intact Medical Recent Development
    • 12.11 Internazionale Medico Scientifica
    • 12.12 Metaltronica
    • 12.13 Sectra
    • 12.14 Terason
    • 12.15 ZAMAR CARE

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      A breast biopsy is the procedure of locating a diseased tissue in the breast and collecting the specimen sample of the area for further examination and diagnosis. Breast biopsies are performed by using minimally invasive biopsy systems, owing to minimal disfigurement and pain. Non-invasive biopsy techniques provide preventive measures that assist physicians in diagnosing and treating high-risk breast cancer. This information prevents the application of chemotherapy in breast cancer, reducing the complexities of chemo-radiations. Vacuum assisted breast biopsy devices (VAB), core needle biopsies and fine needle aspiration biopsy are commonly used to perform biopsy procedures.
      Approximately 12% women in the U.S. are likely to develop breast cancer during their lifetime. Factors contributing to rise in breast cancer cases is over consumption of alcoholic drinks, lack of physical exercise, improper diet and eating habits, high level of hormonal imbalance & exposure of skin to intense sunlight. However, limited awareness among female population and substandard healthcare facilities especially in developing regions are the factor restraining the growth of breast biopsy market.
      North America is expected to account for the largest share of the breast biopsy market, followed by Europe. However, Asia-Pacific is expected to register a higher growth rate during the forecast period. The growth of the breast biopsy market in Asia-Pacific will be centered on China and India.
      In 2018, the global Breast Biopsy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Breast Biopsy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Breast Biopsy development in United States, Europe and China.

      The key players covered in this study
      BD
      C.R. Bard
      Hologic
      Leica Biosystems
      Argon Medical Devices
      Aurora Imaging
      Carestream Health
      Cook Medical
      Fischer Medical Technologies
      Intact Medical
      Internazionale Medico Scientifica
      Metaltronica
      Sectra
      Terason
      ZAMAR CARE

      Market segment by Type, the product can be split into
      Needle-Based Biopsy Systems
      Breast Biopsy Needles
      Biopsy Imaging Guidance Systems
      Others

      Market segment by Application, split into
      Hospitals
      ASCs
      Research Centers

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Breast Biopsy status, future forecast, growth opportunity, key market and key players.
      To present the Breast Biopsy development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Breast Biopsy are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now